Analystreport

Dyne Therapeutics (DYN) had its "buy" rating reaffirmed by Chardan Capital. They now have a $38.00 price target on the stock.

Dyne Therapeutics, Inc.  (DYN) 
Last dyne therapeutics, inc. earnings: 11/1 04:30 pm Check Earnings Report
US:NYSE Investor Relations: dynegy.com/investors/presentations-events